Cocaine as a risk factor for neuroleptic-induced acute dystonia

Journal of Clinical Psychiatry

Volumn 59, Issue 3, 1998, Pages 128-130

  Van Harten, Peter N ^a,b,f   Van Trier, Jan C A M ^c   Horwitz, Ernst H ^a,d   Matroos, Glenn E ^a   Hoek, Hans W ^e  

^a Psychiatric Hospital   (Netherlands Antilles)

^b Psychiatric Hospital Wellerhof   (Netherlands)

^c Overvecht Hospital   (Netherlands)

^d RIAGG   (Netherlands)

^e Psychiatric Center Rosenburg   (Netherlands)

^f Psychiatric Hospital Welterhof   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPENTHIXOL; COCAINE; DOPAMINE RECEPTOR; DROPERIDOL; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVODOPA; NEUROLEPTIC AGENT; PENFLURIDOL; PHENYTOIN; PIMOZIDE; PROMETHAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DYSTONIA; HUMAN; MALE; MANIA; PRIORITY JOURNAL; RECEPTOR BLOCKING; RISK FACTOR; SCHIZOPHRENIA;

EID: 0031895913     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0307     Document Type: Article

References (10)

1. Casey DE. Neuroleptic-induced acute dystonia. In: Lang AE, Weiner WJ, eds. Drug-Induced Movement Disorders. Mount Kisco, NY: Futura Publishing; 1992:21-40
2. Kumor KM, Sherer MA, Jaffe JH. Haloperidol-induced dystonia in cocaine addicts. Lancet 1986;2:1341-1342
3. Hegarty AM, Lipton RB, Merriman AE, et al. Cocaine as a risk factor for acute dystonic reactions. Neurology 1991;41:1670-1672
4. van Harten PN, Matroos GE, Hoek HW, et al. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia: the Curaçao Extrapyramidal Syndromes Study, I. Schizophr Res 1996;19(pt 1):195-203
5. Moleman P. Praktische Psychofarmacologie. Houten/Zaventem, The Netherlands: Bonn Stafleu Van Loghum; 1992
6. United Nations International Drug Control Program. Recommended Methods for the Detection and Assay of Cocaine, Amphetamine, Methamphetamine and Ring-Substituted Amphetamine Derivatives in Biological Specimens. New York, NY: United Nations; 1993
7. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds. Movement Disorders 2. London, England: Butterworth; 1987:332-358
8. Altman DG. Practical Statistics for Medical Research. London, England: Chapman and Hall; 1991
9. Shaner A, Khalsa ME, Roberts L, et al. Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 1993;150:758-762
10. Giros B, Jaber M, Jones SR, et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-612